The compound is commonly encountered in anhydrous form or as a hexahydrate (commonly called, respectively, "monohydrate" or PBS-1 and "tetrahydrate" or PBS-4, after the historic assumption that NaBO3 would be the anhydrous form).[2] They are both white, odorless, water-soluble solids.[3]
Sodium perborate was first obtained in 1898, independently, by Sebastian Tanatar and by P. Melikoff and L. Pissadewsky; the researchers prepared sodium perborate by treating sodium borate with a solution of hydrogen peroxide and sodium hydroxide, but Tanatar also obtained sodium perborate by electrolysis of a solution of sodium borate.[4][5][6]
The compound also crystallizes from water as the hexahydrate, Na2H4B2O8·6H2O, that is, Na2H16B2O14 or NaH8BO7.[citation needed]
The anhydrous compound is commonly but incorrectly called a "monohydrate" after the historical formulation NaBO3·H2O instead of the correct Na2H4B2O8. Likewise, the hexahydrate is usually called "tetrahydrate" and formulated as NaBO3·4H2O.[2] Both forms are white, odorless, water-soluble solids.[3] The "monohydrate" and the "tetrahydrate" are the commercially important forms.[3]
There does exist a true tetrahydrate Na2H4B2O8·4H2O, traditionally known as the "trihydrate", with no industrial significance. There is a CAS number for each of the three traditional "hydrates", the three "peroxyborate" versions of each (interpreted as a hydrogen peroxide adduct) and the poorly-defined "anhydrate" NaBO3, totalling seven.[1]
More precisely, in solution the cyclic anion hydrolizes into two anions [B(OH)3(OOH)]−, which then enter in equilibrium with boric acidB(OH)3, hydrogen peroxide H2O2, the hydroperoxyl anion −OOH, and the tetrahydroxyborate anion [B(OH)4]−:[2]
[(B(OH)2OO)2]2− + 2 H2O ⇌ 2 [B(OH)3(OOH)]−
[B(OH)3(OOH)]− ⇌ B(OH)3 + −OOH
B(OH)3 + −OOH + H2O ⇌ [B(OH)4]− + H2O2
As the concentration of the solution increases, other peroxoborate species become significant. With excess H2O2, the anions [B(OH)2(OOH)2]−, [B(OH)(OOH)3]−, and eventually [B(OOH)4]− appear. At high borate concentrations, the sodium perborate with dimeric anion crystallizes out, due to its relatively low solubility.[2]
The "monohydrate" form dissolves faster than the "tetrahydrate" and has higher heat stability; it is prepared by heating the "tetrahydrate".[1] The commercial "anhydrate", or Oxoborate, is prepared by further heating of "monohydrate" and actually consists of sodium borate and boron–oxygen radical.[1]
Preparation
Sodium perborate is manufactured by reaction of boraxNa2B4O7 and sodium hydroxide NaOH to give sodium metaborateNaBO2, which is then reacted with hydrogen peroxide to give hydrated sodium perborate:[3][9]
It may also be produced in the electrolysis of an aqueous solution containing borax, sodium carbonate and sodium bicarbonate (potassium dichromate is added to improve yield along with sodium silicate). A copper pipe is used as a cathode and platinum for the anode, the current being 6 amperes at 7 to 8 volts, and the temperature 10°C.[12]
Sodium perborate monohydrate is quickly hydrolyzed into hydrogen peroxide and borate on contact with water.[3] A 1979 double-blind crossover study[15] suggests that hydrogen peroxide, which is released during the use of this product, may prevent or retard colonization and multiplication of anaerobic bacteria, such as those that inhabit oral wounds.
Sodium perborate is also present in some tooth bleaching formulas for non vital root treated teeth. The compound is inserted in the root canal and left in place for an extended period of time to allow it to diffuse into the tooth and bleach stains from the inside out. However, this use has been banned in the European Union.[16]
Safety
In the European Union, sodium perborate, like most borates, was classified as "carcinogenic, mutagenic, or toxic for reproduction" (CMR), category 1B of Regulation (EC) 790/2009, as a result of being included in Part 3 of Annex VI of the regulation 1272/2008 on Classification, Labelling and Packaging (CLP) of substances and mixtures. As a result, their use has been automatically banned in cosmetic products in the EU, in any concentration, starting 1 December 2010. That extends to the use of perborates for tooth whitening.[16]
Brands
Bocasan
Bocasan was an oral wound cleanser manufactured in the United Kingdom by Knox Laboratories Ltd of London from 1960–1975,[17] before being rebranded as an Oral-B product
[18]
Production of Bocasan appears to have ceased by 2003. A similar product, Amosan was available for a period before also ceasing production in 2010. As of 2013, a Dutch pharmacy offers the same formulation under the name Bikosan[19]
It was used to aid treatment, in adults or children over 5 years old, of periodontal conditions such as canker sores, denture irritation, orthodontic irritation, or after dental procedures.
Bocasan was packaged in a 1.7 gram envelope, and contained 69.72% sodium perborate monohydrate and 29.68% sodium hydrogen tartrate anhydrous. To use, the contents were dissolved in 30 cubic centimetres of warm water. Half the amount was swilled around the mouth for two minutes and discarded, and the procedure repeated with the remainder. Treatment was recommended three times a day after meals.
A 1979 double-blind crossover study[20] suggests that hydrogen peroxide, which is released during the use of this product, may prevent or retard colonization and multiplication of anaerobic bacteria, such as those that inhabit oral wounds. A small (n=12) 1998 RCT shows that Bocasan combined with chlorhexidine mouthwash is better than chlorhexidine alone in preventing plaque.[21] A further study (n=28) shows that Bocasan reduces the staining associated with chlorhexidine.[22]
Normal use: Use up to three times daily, after meals or as directed by a dentist
Amosan
Amosan[23] is an oral antisepticrinse. It contains 68.635% sodium perborate monohydrate by weight. Sold as a powder customarily packaged in 1.7g envelopes, it reconstitution with warm water, after which it is used as a mouth rinse. It is used to aid in the prevention of, as well as speed the recovery from canker sores, denture irritation, orthodontic irritation, and oral injuries or after dental procedures.
History
Amosan was originally made by Oral-B; a mention of the powder appeared in the February 6, 1970 Federal Register.[24] Between 2005 and 2010, Amosan was manufactured in Belgium and sold under the Oral-B brand, belonging to Procter & Gamble after its 2005 acquisition of Gillette. In December 2010, its use was banned in the EU, as the product is based on borate, which the union considers "carcinogenic, mutagenic, or toxic for reproduction".[16]
Vintage Brands Limited began manufacturing and selling Amosan Oral Antiseptic Rinse in 2014 because many consumers were disappointed that it was no longer available.[25] Product review pages on Amazon[26] and public comment forums elsewhere[27] indicate a high level of frustration with the discontinuation by users who could find no effective alternative treatment.
In April 2012, it was reported that Shoppers Drug Mart in Canada had produced a comparable product under their house brand: 'Life Brand Oral Wound Cleanser'.[28] Also, Jean Coutu and Rexall has their own house brand versions.
^ abcdAlexander McKillop and William R Sanderson (1995): "Sodium perborate and sodium percarbonate: Cheap, safe and versatile oxidising agents for organic synthesis". Tetrahedron, volume 51, issue 22, pages 6145-6166. doi:10.1016/0040-4020(95)00304-Q
^ abcdefgB.J. Brotherton "Boron: Inorganic Chemistry" in Encyclopedia of Inorganic Chemistry (1994) Ed. R. Bruce King, John Wiley & Sons ISBN0-471-93620-0
^Tanatar, S. (1898). "Perborate und ihre Konstitution" [Perborates and their composition]. Zeitschrift für physikalische Chemie (Journal for Physical Chemistry) (in German). 26: 132–134.
Tanatar, S. (1898). "Notiz über Perborate" [Notice about perborates]. Zeitschrift für physikalische Chemie (in German). 29: 162–166.
Tanatar, S. (1901). "Über Perborate" [About perborates]. Zeitschrift für anorganische und allgemeine Chemie (Journal for Inorganic and General Chemistry) (in German). 26: 345–347.
^Melikoff, P.; Pissadewsky, L. (1898). "Hypertitanate und Hyperborate". Berichte der Deutschen Chemischen Gesellschaft (in German). 31: 678–680.
^Jakob, Harold; Leininger, Stefan; Lehmann, Thomas; Jacobi, Sylvia; Gutewort, Sven (2007). "Ch. 26: Peroxo Compounds, Inorganic". Ullmann's Encyclopedia of Industrial Chemistry. Vol. A19. Hoboken, New Jersey, USA: Wiley‐VCH Verlag GmbH & Co. pp. 293–324. doi:10.1002/14356007.a19_177.pub2. See p. 299.
^Carrondo, M. A. A. F. de C. T.; Skapski, A. C. (1978). "Refinement of the X-ray crystal structure of the industrial bleaching agent disodium tetrahydroxo-di-μ-peroxo-diborate hexahydrate, Na2[B2(O2)2(OH)4]·6H2O". Acta Crystallogr B. 34: 3551. doi:10.1107/S0567740878011565.
^J. Dugua and B.Simon (1978): "Crystallization of sodium perborate from aqueous solutions: I. Nucleation rates in pure solution and in presence of a surfactant". Journal of Crystal Growth, volume 44, issue 3, pages 265-279.doi:10.1016/0022-0248(78)90025-8
^J. Dugua and B.Simon (1978): "Crystallization of sodium perborate from aqueous solutions: II. Growth kinetics of different faces in pure solution and in the presence of a surfactant". Journal of Crystal Growth, volume 44, issue 3, pages 280-286.doi:10.1016/0022-0248(78)90026-X
^Wennstrom, Jan; Lindhe, Jan (Apr 1979). "Effect of hydrogen peroxide on developing plaque and gingivitis in man". J Clin Periodontol. 6 (2): 115–30. doi:10.1111/j.1600-051x.1979.tb02190.x. PMID379049.
^ abcNature Inc. (2015): "Chemical used in beauty salon teeth whitening banned by EU". BDJ Team, volume 2, article 15075, 26 June 2015. doi:10.1038/bdjteam.2015.75
^Wennstrom, Jan; Lindhe, Jan (April 1979). "Effect of hydrogen peroxide on developing plaque and gingivitis in man". Journal of Clinical Periodontology. 6 (2): 115–30. doi:10.1111/j.1600-051x.1979.tb02190.x. PMID379049.
^Dona, BL; Gründemann, LJ; Steinfort, J; Timmerman, MF; van der Weijden, GA (November 1998). "The inhibitory effect of combining chlorhexidine and hydrogen peroxide on 3-day plaque accumulation". Journal of Clinical Periodontology. 25 (11 Pt 1): 879–83. doi:10.1111/j.1600-051x.1998.tb02385.x. PMID9846796.
^Gründemann, LJ; Timmerman, MF; Ijzerman, Y; van der Weijden, GA; van der Weijden, GA (January 2000). "Stain, plaque and gingivitis reduction by combining chlorhexidine and peroxyborate". Journal of Clinical Periodontology. 27 (1): 9–15. doi:10.1034/j.1600-051x.2000.027001009.x. PMID10674956.